Following the ever-increasing public pressure on the German Federal Government, the German Drugs Commissioner Marlene Mortler has announced what just a few months ago seemed unthinkable: Germany, just like the Netherlands and Canada, will establish a Cannabis Agency in order to care for its patients itself in future. Up until now, the German Government has insisted that there is no need for such an institution.
The German Hemp Association welcomes the announcement by the federal government in Germany to set up a cannabis agency. This paves the way for the first cultivation of medicinal cannabis in Germany, helping not only the patients, but allowing also new economic prospects for Germany.
On October 16th, the 4th edition of the conference on pharmacological advances and therapeutic uses of cannabinoids in medicine took place at the medical faculty of Strasbourg. Organised by the UFCM iCare organisation (French Union for the use of Cannabinoids in Medicine) the conference was presided over by French patient and activist Bertrand Rambaud.
Cystic fibrosis is a severe and debilitating genetic disorder that significantly reduces life expectancy and quality of life in sufferers. Now, evidence is emerging of the endocannabinoid system's fundamental role in the disorder.
The Czech Republic is a landlocked Central European nation with a population of around 10.5 million. The Czech Republic has a long history of utilising cannabis, and in modern times boasts some of the world’s most progressive cannabis laws—although these laws have been sorely tested on more than one occasion.
Bertrand Rambaud is a French activist and patient. Fellow French cannabis patients may also know him as the co-founder and President of UFCM iCare, an association focused on medicinal cannabis, and more precisely, on medical research aiming at the use of cannabinoids in medicine.
On the basis of a research report, the parliament of the Australian state of Victoria is determined to legalise a number of medicinal cannabis products. This is a serious step forward for a country that has struggled for a long time with the issue of legalisation of medicinal cannabis and recreational cannabis consumption. Read more about this significant decision here.
This Saturday, the association “Union Francophone pour les Cannabinoïdes en Médecine” (“French-speaking Union for the use of Cannabinoids in Medicine”) also known as UFCM iCare, is holding its yearly symposium. The event will welcome hundreds of healthcare professionals from all over the world, gathered in order to discuss research focused on the use of cannabinoids in medicine.
Berlin was asked and has answered. 39% of interviewees are for the legalisation of cannabis, as the German Hemp Association (DHV) reported on October 2nd, 2015. Further details about the poll can be found in the following article.
Cannabis is known to be an efficient solution to serious dermatological conditions. Indeed, scientific studies have proven that cannabinoids as well as hemp seed oil have a positive impact on many issues, and can also improve overall skin quality.
On Friday the 2nd of October 2015 the house of South African medicinal cannabis oil producer and cannabis activist Sheldon Cramer - also known as Bobby Greenhash and 'the Robin Hood of cannabis oil' - was raided. Cramer, who was not home at the time, went into hiding with his family in the ZwaZulu Natal bush.
The history of medical cannabis is long and turbulent, encompassing almost every corner of the globe and spanning over 6,000 years. Here, we set out what we believe are the most significant milestones on the long march to gain recognition of cannabis as a powerful, effective, and safe medicine.
Attention deficit disorder or attention deficit hyperactivity disorder (ADD/ADHD) is a neurological disorder characterized by impulsiveness, inattention and hyperactivity. ADD/ADHD is one of a group of neuropsychiatric conditions (that also includes schizophrenia and autism) now linked to a dysfunctional endocannabinoid system.
Autism spectrum disorders (ASDs) are characterized by difficulty with social interaction, repetitive behaviour and limited empathy with peers. Some forms of autism also lead to cognitive and linguistic impairment, although Asperger’s syndrome is an exception to this. So what role does the endocannabinoid system have to play?
There is a growing body of evidence to suggest that the endocannaboid system has a fundamental role to play in various aspects of the aging process, both mental and somatic. Furthermore, regular use of cannabis itself may assist in slowing down this process, although the precise mechanism of action has not been ascertained.
The Scientist is a documentary that tells the story of Nobel price nominee Prof. Raphael Mechoulam. It dives into his early days as a child of the Holocaust in Bulgaria, his immigration to Israel, and his career as the chief investigator into the chemistry and biology of the world’s most misunderstood plant: Cannabis Sativa L.
Myalgic encephalopathy (ME) is a complex and controversial disorder characterized by chronic symptoms of fatigue that have no apparent cause and are not relived by rest. Although there is very little empirical research into the potential for cannabis to treat ME, countless sufferers report feeling subjective relief.
The menopause is the term for the stage of life wherein a human female ceases to menstruate, and permanently loses the ability to have children. Strictly, menopause refers to the point at which a woman has not experienced a menstrual period for twelve months; the years of biological disturbances either side of this point are known as the 'perimenopause'.
Those of you who have read my previous blogs for Sensi Seeds will know that I have written about Michelle X before. She has recently had a new wave of attention after TV broadcaster Channel 5 portrayed her as a benefit scrounger – completely ignoring the basic facts of how cannabis has been scientifically proven to help with MS.